Unknown

Dataset Information

0

The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia.


ABSTRACT: It is unclear how the 22q11.2 deletion predisposes to psychiatric disease. To study this, we generated induced pluripotent stem cells from deletion carriers and controls and utilized CRISPR/Cas9 to introduce the heterozygous deletion into a control cell line. Here, we show that upon differentiation into neural progenitor cells, the deletion acted in trans to alter the abundance of transcripts associated with risk for neurodevelopmental disorders including autism. In excitatory neurons, altered transcripts encoded presynaptic factors and were associated with genetic risk for schizophrenia, including common and rare variants. To understand how the deletion contributed to these changes, we defined the minimal protein-protein interaction network that best explains gene expression alterations. We found that many genes in 22q11.2 interact in presynaptic, proteasome, and JUN/FOS transcriptional pathways. Our findings suggest that the 22q11.2 deletion impacts genes that may converge with psychiatric risk loci to influence disease manifestation in each deletion carrier.

SUBMITTER: Nehme R 

PROVIDER: S-EPMC9237031 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia.

Nehme Ralda R   Pietiläinen Olli O   Artomov Mykyta M   Tegtmeyer Matthew M   Valakh Vera V   Lehtonen Leevi L   Bell Christina C   Singh Tarjinder T   Trehan Aditi A   Sherwood John J   Manning Danielle D   Peirent Emily E   Malik Rhea R   Guss Ellen J EJ   Hawes Derek D   Beccard Amanda A   Bara Anne M AM   Hazelbaker Dane Z DZ   Zuccaro Emanuela E   Genovese Giulio G   Loboda Alexander A AA   Neumann Anna A   Lilliehook Christina C   Kuismin Outi O   Hamalainen Eija E   Kurki Mitja M   Hultman Christina M CM   Kähler Anna K AK   Paulo Joao A JA   Ganna Andrea A   Madison Jon J   Cohen Bruce B   McPhie Donna D   Adolfsson Rolf R   Perlis Roy R   Dolmetsch Ricardo R   Farhi Samouil S   McCarroll Steven S   Hyman Steven S   Neale Ben B   Barrett Lindy E LE   Harper Wade W   Palotie Aarno A   Daly Mark M   Eggan Kevin K  

Nature communications 20220627 1


It is unclear how the 22q11.2 deletion predisposes to psychiatric disease. To study this, we generated induced pluripotent stem cells from deletion carriers and controls and utilized CRISPR/Cas9 to introduce the heterozygous deletion into a control cell line. Here, we show that upon differentiation into neural progenitor cells, the deletion acted in trans to alter the abundance of transcripts associated with risk for neurodevelopmental disorders including autism. In excitatory neurons, altered t  ...[more]

Similar Datasets

| S-EPMC5658953 | biostudies-literature
| S-EPMC3129332 | biostudies-other
| S-EPMC4506960 | biostudies-literature
| S-EPMC10686339 | biostudies-literature
| S-EPMC5126788 | biostudies-literature
| S-EPMC4240070 | biostudies-literature
| S-EPMC6543121 | biostudies-literature
| S-EPMC10362570 | biostudies-literature
| S-EPMC6358611 | biostudies-literature
| S-EPMC8580139 | biostudies-literature